Common Contracts
1 similar Clinical Trial Agreement contracts
Amendment No. 3 to the Clinical Trial Agreement dated 03 September 2010 for the Ponesimod study/AC-058B202 between ACTELION Pharmaceuticals Ltd Gewerbestrasse 164123 Allschwil Switzerland(hereinafter “ACTELION”) andFakultní nemocnice u sv. Anny v...Clinical Trial Agreement • October 23rd, 2018
AMENDMENT 3 TO THE Agreement on Conducting a Clinical Study / DODATEK 3 keSmlouvě o provedení klinické studie This Amendment 3 (the “Amendment”) to the Agreement on Conducting a Clinical Study] dated 03 September 2010 as amended with Amendment No. 1 entered on 06 July 2012 and Amendment No. 2 entered on 11 June 2015 (the “ Agreement”) for the clinical study conducted in accordance with the Protocol AC-058B202 titled: “ Multicenter, randomized, double-blind, parallel-group extension to AC-058B201 to investigate the long-term safety, tolerability, and efficacy of 10, 20 and 40mg/day ACT-128800, an oral S1P1 receptor agonist, in patients with relapsing-remitting multiple sclerosis.” thereto (the “Study”), Smluvní strany se dohodly na tomto Dodatku č. 3 (dále jen „Dodatek“) ke Smlouvě o provedení klinické studie uzavřené ke dni03. Září 2010 ve znění dodatku č. 1 ze dne 06.07.2012 a dodatku č. 2 ze dne 11.6.2015 dále jen „Smlouva“) o klinickém hodnocení prováděném v souladu s Protokolem č
